Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:10:43 EDT Tue 30 Sep 2025
Enter Symbol
or Name
USA
CA



Q:ELTP - ELITE PHARMACEUTICALS INC - https://www.elitepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ELTP - Qnot subscribed0.6401-0.036825-5.41,939.81,2614030.6525  0.6943  0.64010.8194  0.2716:00:01Aug 1415 min RT 2¢

Recent Trades - Last 10 of 403
Time ETExPriceChangeVolume
16:00:01Q0.6411-0.035825514
15:59:51Q0.6401-0.03682532,350
15:59:48Q0.645-0.0319255,000
15:59:46Q0.645-0.0319252,000
15:59:38Q0.647-0.0299251,000
15:59:36Q0.646-0.0309251,625
15:59:34Q0.6477-0.0292252,000
15:59:33Q0.649-0.0279252,890
15:59:24Q0.6491-0.027825196
15:59:22Q0.65-0.0269251,700

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-08-14 16:26U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information
2025-08-08 16:31U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2026 Financial Results on August 15, 2025
2025-06-30 16:15U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information
2025-06-23 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2025 Financial Results on July 1, 2025
2025-06-16 07:01U:ELTPNews ReleaseElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
2025-04-30 16:31U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
2025-03-03 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
2025-02-13 16:23U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information
2025-02-10 16:55U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025
2024-12-26 07:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
2024-12-02 06:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
2024-11-18 06:01U:ELTPNews ReleaseElite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
2024-11-14 16:39U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information
2024-11-07 07:02U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024
2024-10-10 16:42U:ELTPNews ReleaseElite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
2024-10-07 07:31U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets